"Health Canada approves Novartis’ Fabhalta for PNH with haemolytic anaemia" was originally created and published by ...

EVANSTON, Ill., Feb. 9, 2025 /PRNewswire/ -- Novartis took home the top spot in the 21st Kellogg School Super Bowl Advertising Review with its "Your Attention, Please" ad putting a spotlight on ...

"Novartis took a risk to really break through ... clinical professor of marketing and co-lead of the school's Ad Review. "The ad started out with a playful tone to then deliver a serious message ...

The FDA has extended its review of Novartis’ potential multiple sclerosis drug ofatumumab, pushing back a decision on the repurposed cancer drug until September this year. Ofatumumab could ...

A crucial challenge in AI today is bridging the gap between general intelligence and deep, organisation-specific knowledge.

Novartis is expanding its prospects in cardiometabolic disease by striking a deal to acquire Anthos Therapeutics, a company in pivotal testing with a blood clot-preventing drug that could offer ...

To boost its cardiovascular pipeline, Novartis has announced the acquisition of the company it co-founded with Blackstone ...

"Novartis took a risk to really break through the clutter with its unexpected focus on breast cancer screening," said Tim Calkins, clinical professor of marketing and co-lead of the school's Ad Review ...